125 related articles for article (PubMed ID: 11181417)
1. A possible role for metalloproteinases in renal cyst development.
Obermüller N; Morente N; Kränzlin B; Gretz N; Witzgall R
Am J Physiol Renal Physiol; 2001 Mar; 280(3):F540-50. PubMed ID: 11181417
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL
Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
4. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
Elberg D; Jayaraman S; Turman MA; Elberg G
Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
[TBL] [Abstract][Full Text] [Related]
6. Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells.
Kadono Y; Shibahara K; Namiki M; Watanabe Y; Seiki M; Sato H
Biochem Biophys Res Commun; 1998 Oct; 251(3):681-7. PubMed ID: 9790969
[TBL] [Abstract][Full Text] [Related]
7. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor.
Ota K; Stetler-Stevenson WG; Yang Q; Kumar A; Wada J; Kashihara N; Wallner EI; Kanwar YS
Kidney Int; 1998 Jul; 54(1):131-42. PubMed ID: 9648071
[TBL] [Abstract][Full Text] [Related]
8. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
9. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis.
Goss KJ; Brown PD; Matrisian LM
Int J Cancer; 1998 Nov; 78(5):629-35. PubMed ID: 9808534
[TBL] [Abstract][Full Text] [Related]
10. Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat.
Schaefer L; Han X; Gretz N; Häfner C; Meier K; Matzkies F; Schaefer RM
Kidney Int; 1996 Jan; 49(1):75-81. PubMed ID: 8770951
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.
Berthier CC; Lods N; Joosten SA; van Kooten C; Leppert D; Lindberg RL; Kappeler A; Raulf F; Sterchi EE; Lottaz D; Marti HP
Kidney Int; 2006 Jan; 69(2):358-68. PubMed ID: 16408127
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
13. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.
Bigatel DA; Elmore JR; Carey DJ; Cizmeci-Smith G; Franklin DP; Youkey JR
J Vasc Surg; 1999 Jan; 29(1):130-8; discussion 138-9. PubMed ID: 9882797
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
15. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis.
Norman JT; Gatti L; Wilson PD; Lewis M
Exp Nephrol; 1995; 3(2):88-9. PubMed ID: 7773643
[No Abstract] [Full Text] [Related]
17. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
Mucha SA; Meleń-Mucha G; Godlewski A; Stepień H
Virchows Arch; 2007 Mar; 450(3):335-41. PubMed ID: 17235567
[TBL] [Abstract][Full Text] [Related]
19. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats.
Deten A; Hölzl A; Leicht M; Barth W; Zimmer HG
J Mol Cell Cardiol; 2001 Jun; 33(6):1191-207. PubMed ID: 11444923
[TBL] [Abstract][Full Text] [Related]
20. Influence of the matrix metalloproteinase inhibitor batimastat (BB-94) on periodontal bone destruction in Sprague-Dawley rats.
Björnsson MJ; Havemose-Poulsen A; Stoltze K; Holmstrup P
J Periodontal Res; 2004 Aug; 39(4):269-74. PubMed ID: 15206921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
